Immediate Impact

1 by Nobel laureates 50 standout
Sub-graph 1 of 25

Citing Papers

Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2024 Standout
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
2023 Standout
1 intermediate paper

Works of Christopher Watters being referenced

Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn’s disease
2020

Author Peers

Author Last Decade Papers Cites
Christopher Watters 149 65 71 19 299
Hui Tong 150 44 50 15 326
Deling Shi 117 96 18 19 297
A Grönwall 132 27 24 15 325
Sadaf Shadan 142 72 28 17 328
Yan-Jun Hu 110 15 42 12 309
Mitsuru Murakami 139 23 20 15 276
A. M. Schechtman 85 23 53 22 321
Yafei Cai 163 44 61 29 288
Yoshimichi Kozuka 151 37 20 24 315
Y Nishimura 98 62 78 15 303

All Works

Loading papers...

Rankless by CCL
2026